Khat

image003

Published by NIH/NIDA 14 May 2025

 

Cannabis vaping is making headlines worldwide, often promoted as a “safer” alternative to smoking. Meanwhile, Drug Trends data from Australia reveal that non-prescribed cannabis use remains high among people who regularly use drugs. But are wider permission models and positive propaganda about cannabis leading to greater engagement, especially among those most at risk? This article dives into Australian data from the Ecstasy and Related Drugs Reporting System (EDRS) and Illicit Drugs Reporting System (IDRS), exploring what’s really happening with cannabis products, vaping, and why honest health education is more critical than ever.

Cannabis Vaping and Drug Trends in Australia (2014–2024): What the Data Tells Us

Cannabis vaping, once an afterthought, now claims a growing share of the global market. Many believe vaping to be less harmful, with marketers highlighting vaping’s lack of smoke and alleged respiratory benefits. However, recent Drug Trends research in Australia challenges some of these assumptions and uncovers troubling patterns.

The Rise of Electronic Vaping Products

Electronic vaping products started as oversized gadgets in the late 1990s. Initially intended to vaporise dried cannabis herb, they eventually shrank, morphing into today’s sleek e-cigarettes. While vaping nicotine products has become mainstream, cannabis vaping is following close behind, spurred in part by changes to medicinal and recreational cannabis laws overseas.

A North American review found a seven-fold increase in monthly cannabis vaping among adolescents, with notable shifts from dried herb to potent cannabis oils. However, the situation in Australia is different, shaped by stricter regulations and unique market conditions.

Drug Trends in Non-Prescribed Cannabis Use

Australia’s EDRS and IDRS surveys collect real-world data on non-prescribed cannabis and cannabinoid-related products. Between 2014 and 2024, most participants in both systems reported using cannabis recently, with rates as high as 90% in the EDRS and 74% in the IDRS.

Hydroponic and Bush Cannabis Still Dominate

  • Hydroponic cannabis was the most popular, with usage rates ranging from 63%–83% among EDRS respondents, and a remarkable 88%–94% for IDRS participants.
  • Bush cannabis also stayed common, with 51%–77% (EDRS) and 37%–54% (IDRS) reporting use.
  • Other cannabis products, such as THC extracts and commercially-prepared edibles, have appeared in recent years, showing increased product diversity—but are far less popular than traditional forms.

Cannabis Vaping Emerges, But Smoking Prevails

Despite media attention around cannabis vaping, the majority of Australians captured in these studies still smoke cannabis. From 2014 to 2024:

  • Smoking remained the dominant route of administration (ROA) in both groups.
  • Cannabis vaping (inhaling/vaporising) trended upward, but stayed a minority choice. Vaporising among EDRS participants increased from 12% to 25%, and from 2% to 9% for IDRS.

Notably, few users chose vaping as their only method. Most combined it with smoking, suggesting the rise in vaping hasn’t replaced traditional habits.

Concerns About Cannabis Vaping and Permission Models

The Problem with Changing Perceptions

There is growing concern that permission models and positive messaging around cannabis use (whether through legislation or social media) may downplay its risks. Vaping, in particular, is surrounded by claims of being a “safer” alternative to smoking. While it’s true that vaping doesn’t involve combustion and may expose users to fewer toxic chemicals, it’s not risk-free.

Key Issues Include:

  • Potency extremes: Some vape oils and extracts reach THC concentrations of 70–90%, far higher than the average 10%–20% in cannabis herb. Highly potent products carry greater risks for dependence, anxiety, and psychosis.
  • Unknown health risks: The long-term effects of inhaling cannabis vapour, especially from unregulated or home-made devices, are not fully understood.
  • Discreet use and normalisation: Portability and subtlety make vaping easier to hide, particularly from parents and teachers. For some users, this can enable more frequent use or uptake at a younger age.
  • Unhealthy dual use: Most vapers continue smoking, increasing overall exposure to both methods. (for complete research WRD News)

Source: https://www.dalgarnoinstitute.org.au/index.php/resources/drug-information-sheets/2672-cannabis-vaping-and-drug-trends-among-youth-in-australia-2014-2024-a-growing-concern?

Khat falls into the class C drug category but it isn’t recorded as a specific drug in seizure data

A decade ago, a stimulative drug that sold for just a few pounds, was banned in the UK. Known as khat, it’s a plant that’s chewed, giving similar effects to amphetamine.

Ten years on from the drugs reclassification, experts say it is still being sold in the UK, in places for ten times more than it cost in 2014.

But there is little data to help understand the true impact of the ban.

Dr Neil Carrier, who carried out postdoctoral research on the drug at the University of Oxford, said it has largely been “forgotten” by authorities and “in terms of understanding drug policy, the bans’ impact should really be researched”.

Mohammed, not his real name, 25, told the BBC that he tried khat in 2018, four years after the ban.

He said: “The thing is, there’s actually quite a lot of it readily available in the UK.

“You can get it in little silver sachet bags that are air-sealed and marketed as herbal facial products, but it’s literally just khat.”

He chewed the drug in a dried form, which has become more common during the past 10 years.

Dr Carrier, who currently works as a social anthropology professor at the University of Bristol, said fresh khat leaves were sold for “around £3 a bundle (250g)” during the 2000s and 2010s.

It was often chewed by Somali, Yemeni and Ethiopian men in group sessions at designated khat cafes, called mafrishes.

He helped produce a government-published literature review around khat’s social harms and legislation in 2011: “Very often as anthropologists, when we think about drugs, we don’t just focus on the drug itself but also how it gets caught up in the wider cultural meanings, wider relationships and power.

“We look at how it becomes a commodity and how the substance fits into society.”

He felt that the ban was a “missed opportunity” to investigate alternative methods of regulating recreational drugs.

“We could see how khat was associated with various issues that were very challenging with communities using khat in the UK.

“But at the time I felt the drug was blamed for these wider issues,” he said.

In the early 2000s Dr Carrier said he often heard people attribute khat to family and social integration problems.

“I would hear things like ’men are not being good fathers as they chewed khat’.

“And ‘people who are chewing khat might, as a consequence, not be looking for work’.

“But in reality, this is only half the picture.

“We often in society give drugs so much power and label them as the cause of problems when really the picture tends to be more blurred and complicated.”

Last year Border Force seized 2,760 hauls of class C drugs.

A Home Office spokesperson said: “Border Force and police work relentlessly to stop illegal drugs from coming into the country and keep them off our streets.

“We have seen a record level of seizures as we continue to use advanced technology, data and greater intelligence to ensure these drugs do not enter the country.”

The UK was one of the last EU countries to reclassify the khat in June 2014.

Prior to this date, more than 2,500 tonnes was annually imported, according to the Advisory Council of the Misuse of Drugs (ACMD).

That is the equivalent weight of around 208 double-decker buses worth of the stimulative drug.

Most of the shipments are thought to have been distributed and sold amongst east-African diaspora communities in Britain, such as Somalis and Ethiopians.

Dr Carrier said khat and cannabis, both plant-based drugs, have a similar policing system which could have contributed to a lack of data on how prevalent less drugs like khat may be.

“A lot of the drugs data gets conflated with data around cannabis and they tend to get pooled together.

“As far as I understand anyways,” he said.

UK Border Force tend to place khat into an “other class ” category, when reporting the drug.

Dr Carrier added: “What people suspected would happen at the time of the ban has happened.

“Khat is now being smuggled in, especially a dried khat, mostly coming in from Ethiopia, and it seems to have become quite popular.

“The people that do still want to consume, even though it’s been banned, can still consume it in a different form.”

Dried khat is less potent than the fresh plant and is said to provide a “less pleasant user experience” in terms of taste and texture.

Dr Carrier said that meant there is still a market for the drug: “Some people, if they can afford it, will still chew the fresh stuff.

“The fresh stuff is £30 to £40 a bundle.

“But there are people still willing to spend that kind of money on it.

“People are still accessing khat.”

Source: https://www.bbc.co.uk/news/articles/c4gpl62dn26o?utm_source=firefox-newtab-en-gb

Filed under: Khat,UK :

Back to top of page

Powered by WordPress